AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
YMAB(Quitar la ciudad)
Y-mAbs Therapeutics·NASDAQ
--
--(--)
Y-mAbs Therapeutics (YMAB) Revenue Breakdown
Y-mAbs Therapeutics (YMAB) Revenue Breakdown: Q2 2025 Business & Regional Performance
Y-mAbs Therapeutics (YMAB) reported total revenue of 19.52M USD in Q2 2025, with its core business segment Product contributing 97.44%. Regionally, United States remained the largest market, accounting for 75.26% of total revenue. Explore Y-mAbs Therapeutics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Y-mAbs Therapeutics (YMAB) reported total revenue of 19.52M USD in Q2 2025, with its core business segment Product contributing 97.44%. Regionally, United States remained the largest market, accounting for 75.26% of total revenue. Explore Y-mAbs Therapeutics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
No Data
